Ryan W. Dellinger, Ph.D. - Publications

2001 University of California, San Diego, La Jolla, CA 
Fibroblast Growth Factor Receptors (FGFRs) in Human Cancer

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Dellinger RW, Liu-Smith F, Meyskens FL. Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis. Journal of Photochemistry and Photobiology. B, Biology. 138: 317-23. PMID 25022944 DOI: 10.1016/J.Jphotobiol.2014.06.006  0.64
2014 Dellinger RW, Garcia AMG, Meyskens FL. Differences in the glucuronidation of resveratrol and pterostilbene: Altered enzyme specificity and potential gender differences Drug Metabolism and Pharmacokinetics. 29: 112-119. PMID 23965644 DOI: 10.2133/Dmpk.Dmpk-13-Rg-012  0.64
2012 Dellinger RW, Matundan HH, Ahmed AS, Duong PH, Meyskens FL. Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells. Plos One. 7: e47696. PMID 23110092 DOI: 10.1371/Journal.Pone.0047696  0.64
2010 Sun D, Chen G, Dellinger RW, Sharma AK, Lazarus P. Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogenetics. Pharmacogenetics and Genomics. 20: 575-85. PMID 20697310 DOI: 10.1097/Fpc.0B013E32833B04Af  0.64
2010 Balliet RM, Chen G, Dellinger RW, Lazarus P. UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 38: 484-90. PMID 20007297 DOI: 10.1124/Dmd.109.030569  0.64
2009 Olson KC, Dellinger RW, Zhong Q, Sun D, Amin S, Spratt TE, Lazarus P. Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1999-2007. PMID 19589876 DOI: 10.1124/Dmd.108.024596  0.64
2009 Balliet RM, Chen G, Gallagher CJ, Dellinger RW, Sun D, Lazarus P. Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype. Cancer Research. 69: 2981-9. PMID 19318555 DOI: 10.1158/0008-5472.Can-08-4143  0.64
Show low-probability matches.